Moderna’s mRNA vaccines to be exempted from advisory committee scrutiny under $2 billion Morrison era deal

10 December 2024 - Critics say exemption ‘deeply concerning’ and risks creating separate assessment systems. ...

Read more →

2023-24 financial results for cost recovery activities for listing medicines on the PBS and designated vaccines on the NIP

4 December 2024 - The PBS and NIP Cost Recovery Implementation Statement has been updated to include 2023-24 end of ...

Read more →

Agenda for the December 2024 PBAC intracycle meeting

6 December 2024 - The agenda for the December 2024 PBAC intracycle meeting is now available. ...

Read more →

Jessica Lawrence’s meds cost her family $75k a year because they’re not listed on the PBS

6 November 2024 - Medications that are subsidised for cancer sufferers are critical to Jess Lawrence’s wellbeing, but because the 25-year-old ...

Read more →

HTA Policy and Methods Review update

3 December 2024 - The Minister for Health and Aged Care, the Hon Mark Butler MP has announced the Implementation Advisory ...

Read more →

Update on the March 2025 meeting

28 November 2024 - As announced by the Minister on 6 November 2024, to process the unprecedented number of submissions for ...

Read more →

Changes to the PBS listings for Opdualag and Vyxeos

1 December 2024 - As of 1 December 2024, combination chemotherapy medicines, Opdualag and Vyxeos, will be transitioned from the Highly ...

Read more →

Schedule of Pharmaceutical Benefits - 1 December 2024

1 December 2024 - The December 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

Agenda for the March 2025 PBAC meeting (version 1)

28 November 2024 - The agenda for the March 2025 PBAC meeting is now available. ...

Read more →

Life changing endometriosis treatment now cheaper

1 December 2024 - For the first time in three decades, women living with endometriosis will now have access to ...

Read more →

Voters clamour for affordable health in election lead-up

30 November 2024 - Threats and delays to affordable medicine access underscore an appetite for higher health spending, with polling placing ...

Read more →

DUSC utilisation analysis public release documents (June 2024) update

22 November 2024 - The utilisation analysis public release documents from the June 2024 DUSC meeting are now available. ...

Read more →

Update from the PBAC (November 2024)

28 November 2024 - An update from the Chair and Deputy Chair of the PBAC is now available. ...

Read more →

Australians benefit from new and expanded medicines on the PBS

20 November 2024 - Australians with osteoporosis, a type of skin lymphoma, spinal muscular atrophy and type 2 diabetes will ...

Read more →

Evidence of clinical benefit of cancer medicines considered for funding in Australia

14 November 2024 - The objective was to describe the type of evidence and the clinical benefit of cancer medicines ...

Read more →